Amgen Inc.

AMGN

Healthcare

$331.36+0.54%vs prev close

$261.43

$391.29

52W Range

-8.89 (-2.61%)Past 1M

Price

Stock Timeline

Institutional Holders

1 Holding · 1 Sold · Q4 2025

Based on ARK ETF real-time + 13F quarterly filings

Ray DalioBridgewater Associates

Decreased

3,020

Portfolio Weight

Est. Value

$988K

vs Prev Quarter

-73% (11K→3K)

Sold · Q4 2025

Cathie WoodARK Invest

Fully Sold

Portfolio Weight

Prev Holdings

101

Est. Sold Value

$38K

Holding Period

13F data may be delayed up to 90 days.

Market Context

Analyst Consensus

※ Analyst opinions are for reference only and do not constitute investment advice. Each securities firm may have different opinions.

Overall Opinion

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Analyst Targets

avg.

$353.07

vs Current ▲ +6.6% upside

Current$331.36

Low ~ High$200.00 ~ $432.00

Firm

Position

Price Target

Upside / Downside

Close Price

Action

Date

Guggenheim

Neutral

$340.00

+2.61%

$323.85

Maintain

2026-05-04

Truist Securities

Hold

$327.00

-1.32%

$329.82

Maintain

2026-05-01

Canaccord Genuity

Hold

$366.00

+10.45%

$344.86

Upgrade

2026-04-21

UBS

Buy

$400.00

+20.71%

$349.82

Maintain

2026-04-13

Morgan Stanley

Equal-Weight

$326.00

-1.62%

$351.02

Maintain

2026-04-10

1 / 1

Avg Target

$353.07

vs Current ▲ +6.6% upside

Hold

35 analysts

Strong Buy 4Buy 9Hold 19Sell 2Strong Sell 1

Low $200.00

Current $331.36

High $432.00

Firm	Position	Target	Upside	Close	Action	Date
Guggenheim	Neutral	$340.00	+2.61%	$323.85	Maintain	26.05.04
Truist Securities	Hold	$327.00	-1.32%	$329.82	Maintain	26.05.01
Canaccord Genuity	Hold	$366.00	+10.45%	$344.86	Upgrade	26.04.21
UBS	Buy	$400.00	+20.71%	$349.82	Maintain	26.04.13
Morgan Stanley	Equal-Weight	$326.00	-1.62%	$351.02	Maintain	26.04.10

1 / 1

Price Information

Previous Close$329.59

Open$329.13

Day Range$329.05 - $332.98

52-Week Range$261.43 - $391.29

1-Year Change19.49%

Trading Volume

Volume1,367,867

Avg Volume (3mo)2,666,963

Valuation

Market Cap178.9B

Book Value$16.07

Shares Outstanding540,000,000

Financials

Revenue (TTM)37.2B

Net Income7.8B

EPS$14.37

EBITDA16.9B

Profitability

P/E Ratio23.06

P/B Ratio20.62

Return on Equity (ROE)101.32%

Return on Assets (ROA)8.35%

Profit Margin20.96%

EV/EBITDA13.19

Beta0.43

Dividend

Dividend Rate$10.08

Dividend Yield306.00%

Technical

RSI(14)36.91

Company Overview

Amgen Inc. is a global biotechnology company that discovers, develops, manufactures, and delivers human therapeutics. Its main products include treatments for conditions like rheumatoid arthritis, osteoporosis, multiple myeloma, and thyroid eye disease, among others. Amgen is a leading player in the biopharmaceutical industry, serving healthcare providers worldwide.

P/B

20.62

High valuation

ROE

101.3%

High return

Beta

0.43

Low volatility

RSI(14)

36.9

Neutral zone

AI-generated summary. Not investment advice.